D

Dare Bioscience
D

DARE

3.18000
USD
0.01
(0.32%)
مغلق
حجم التداول
945
الربح لكل سهم
-2
العائد الربحي
-
P/E
-5
حجم السوق
27,667,237
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ATHE
    0.13000
    (3.24%)
    4.14000 USD
    C
    CAPR
    -0.146
    (-0.96%)
    15.010 USD
    C
    CCS
    -2.120
    (-2.89%)
    71.160 USD
    M
    MRSN
    -0.00070
    (-0.13%)
    0.53480 USD
    P
    PRQR
    -0.02000
    (-0.77%)
    2.57000 USD
    المزيد
الأخبار
المقالات

العنوان: Dare Bioscience Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women'shealth and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.